Publikationen in Zusammenarbeit mit Forschern von Hospital Juan Ramón Jiménez (15)

2023

  1. EN-DALBACEN 2.0 Cohort: real-life study of dalbavancin as sequential/consolidation therapy in patients with infective endocarditis due to Gram-positive cocci

    International Journal of Antimicrobial Agents, Vol. 62, Núm. 3

2022

  1. Ampicillin plus ceftriaxone combined therapy for enterococcus faecalis infective endocarditis in opat

    Journal of Clinical Medicine, Vol. 11, Núm. 1

  2. Weight changes after first-line antiretroviral initiation in a cohort of HIV-positive patients in Southern Spain (CAPOTA study)

    International Journal of STD and AIDS, Vol. 33, Núm. 13, pp. 1119-1123

2021

  1. Blood culture-negative infective endocarditis: a worse outcome? Results from a large multicentre retrospective Spanish cohort study

    Infectious Diseases, Vol. 53, Núm. 10, pp. 755-763

2020

  1. Clinical and prognostic differences between methicillin-resistant and methicillin-susceptible Staphylococcus aureus infective endocarditis

    BMC Infectious Diseases, Vol. 20, Núm. 1

2019

  1. DALBACEN cohort: Dalbavancin as consolidation therapy in patients with endocarditis and/or bloodstream infection produced by gram-positive cocci

    Annals of Clinical Microbiology and Antimicrobials, Vol. 18, Núm. 1

  2. Role of age and comorbidities in mortality of patients with infective endocarditis

    European Journal of Internal Medicine, Vol. 64, pp. 63-71

2013

  1. Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating enterococcus faecalis infective endocarditis

    Clinical Infectious Diseases, Vol. 56, Núm. 9, pp. 1261-1268

  2. Neurological complications of infective endocarditis risk factors, outcome, and impact of cardiac surgery: A multicenter observational study

    Circulation, Vol. 127, Núm. 23, pp. 2272-2284

2011

  1. Surgical treatment for infective endocarditis in elderly patients

    Journal of Infection, Vol. 63, Núm. 2, pp. 131-138

2010

  1. Streptococcus agalactiae left-sided infective endocarditis. Analysis of 27 cases from a multicentric cohort

    Journal of Infection, Vol. 61, Núm. 1, pp. 54-59

2009

  1. Endocarditis por enterococo: análisis multicéntrico de 76 casos

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 27, Núm. 10, pp. 571-579

  2. Prognostic factors in left-sided endocarditis: Results from the andalusian multicenter cohort

    BMC Infectious Diseases, Vol. 10

2008

  1. Left-sided native valve endocarditis by coagulase-negative staphylococci: An emerging disease

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. 5, pp. 263-268

2006

  1. Registrolesaf. Características de los pacientes con lupus eritematoso sistémico síndrome antifosfolipídico registrados por usuarios médicos especialistas en reumatología y medicina interna

    Reumatologia Clinica, Vol. 2, Núm. 3, pp. 131-136